Biotechnology News

Adneuris will share new abuse potential data for cebranopadol that demonstrates that its abuse potential may be lower than schedule IV pain drugs Previously announced Phase 3 studies have...

OXFORD, United Kingdom and BURLINGTON, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP), a late-stage clinical immuno-oncology company developing active immunotherapies...

JERSEY CITY, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Claris Biotherapeutics, Inc., a late-stage biopharmaceutical company dedicated to advancing transformative therapies for sight-threatening...

PLYMOUTH MEETING, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore data from the company’s investigation of...

PITTSBURGH, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 2026 Cantor Global Healthcare Conference...

LONDON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tangram Therapeutics (“Tangram”), a company committed to unlocking transformative RNAi medicines for meaningful patient impact, today announced progression...

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant...

PRINCETON, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage,...

Damora Therapeutics announced that it granted inducement equity awards to three newly hired, non-executive employees on September 1, 2026.

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease...